Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
07 2021
Historique:
received: 11 11 2020
revised: 22 12 2020
accepted: 25 01 2021
pubmed: 7 3 2021
medline: 3 9 2021
entrez: 6 3 2021
Statut: ppublish

Résumé

The objective of this study was to assess trends in the use as well as the outcomes of patients undergoing simultaneous versus staged resection for synchronous colorectal liver metastases. Patients undergoing resection for colorectal liver metastases between 2008 and 2018 were identified using a multi-institutional database. Trends in use and outcomes of simultaneous resection of colorectal liver metastases were examined over time and compared with that of staged resection after propensity score matching. Among 1,116 patients undergoing resection for colorectal liver metastases, 690 (61.8%) patients had synchronous disease. Among them, 314 (45.5%) patients underwent simultaneous resection, while 376 (54.5%) had staged resection. The proportion of patients undergoing simultaneous resection for synchronous colorectal liver metastases increased over time (2008: 37.2% vs 2018: 47.4%; p While simultaneous resection was associated with increased morbidity, the incidence of severe morbidity decreased over time. Long-term survival was comparable after simultaneous resection versus staged resection of colorectal liver metastases.

Sections du résumé

BACKGROUND
The objective of this study was to assess trends in the use as well as the outcomes of patients undergoing simultaneous versus staged resection for synchronous colorectal liver metastases.
METHODS
Patients undergoing resection for colorectal liver metastases between 2008 and 2018 were identified using a multi-institutional database. Trends in use and outcomes of simultaneous resection of colorectal liver metastases were examined over time and compared with that of staged resection after propensity score matching.
RESULTS
Among 1,116 patients undergoing resection for colorectal liver metastases, 690 (61.8%) patients had synchronous disease. Among them, 314 (45.5%) patients underwent simultaneous resection, while 376 (54.5%) had staged resection. The proportion of patients undergoing simultaneous resection for synchronous colorectal liver metastases increased over time (2008: 37.2% vs 2018: 47.4%; p
CONCLUSION
While simultaneous resection was associated with increased morbidity, the incidence of severe morbidity decreased over time. Long-term survival was comparable after simultaneous resection versus staged resection of colorectal liver metastases.

Identifiants

pubmed: 33674128
pii: S0039-6060(21)00079-9
doi: 10.1016/j.surg.2021.01.041
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-166

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Diamantis I Tsilimigras (DI)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: https://twitter.com/DTsilimigras.

Kota Sahara (K)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

J Madison Hyer (JM)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

Adrian Diaz (A)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

Dimitrios Moris (D)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

Fabio Bagante (F)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH; Department of Surgery, University of Verona, Italy.

Alfredo Guglielmi (A)

Department of Surgery, University of Verona, Italy.

Andrea Ruzzenente (A)

Department of Surgery, University of Verona, Italy.

Sorin Alexandrescu (S)

Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.

George Poultsides (G)

Department of Surgery, Stanford University, CA.

Kazunari Sasaki (K)

Department of General Surgery, Cleveland Clinic Foundation, OH.

Federico Aucejo (F)

Department of General Surgery, Cleveland Clinic Foundation, OH.

Aslam Ejaz (A)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

Jordan M Cloyd (JM)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

Timothy M Pawlik (TM)

Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: tim.pawlik@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH